Gabapentin NDC 72888-131

NDC codes

FDA NDC Directory

Product NDC (as listed)72888-131Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72888-0131Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72888-131-00	72888013100	1000 TABLET in 1 BOTTLE (72888-131-00)Marketed from Sep 22, 2022
72888-131-01	72888013101	100 TABLET in 1 BOTTLE (72888-131-01)Marketed from Sep 22, 2022
72888-131-05	72888013105	500 TABLET in 1 BOTTLE (72888-131-05)Marketed from Sep 22, 2022
72888-131-30	72888013130	30 TABLET in 1 BOTTLE (72888-131-30)Marketed from Sep 22, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 600 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Advagen Pharma Ltd
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077661
Marketing start: Sep 22, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 72888-131_4b9217ba-8356-aab1-e063-6294a90a2dceSPL ID 4b9217ba-8356-aab1-e063-6294a90a2dceSPL set ID 401b30fc-e143-4906-aae1-e5b5c190d4a8RxCUI 310433, 310434UNII 6CW7F3G59XUPC 0372888132303, 0372888131306, 0372888131016, 0372888131009, 0372888132006, 0372888131054, 0372888132013, 0372888132051

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472888013100 followed by a unit qualifier and the quantity

Package 72888-0131-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 24, 2026.

Indications (excerpt from the label)

Gabapentin is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin is indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077661

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077661
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 800 mg/1	TabletOral	Advagen Pharma Ltd	72888-132